Clinical Cancer Research, Vol 4, Issue 9 2265-2272, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck

DK Frank, TJ Liu, MJ Frederick and GL Clayman
Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

Ample data exist contending that wild-type p53 and E2F-1 cooperate to mediate apoptosis, that E2F-1-mediated apoptosis is p53 dependent in some situations, and that E2F-1 can induce accumulation of p53 in mammalian cells. These data support the investigation of the biological consequences of combined wild-typep53 and E2F-1 overexpression in human squamous cell carcinoma of the head and neck (SCCHN) for the purpose of developing apoptosis-inducing molecular intervention strategies for the management of this devastating disease. The recombinant adenovirus (Ad) vectors Ad-p53 and Ad-E2F-1 were used for wild-type p53 and E2F-1 gene transfers, respectively, into SCCHN cell lines TU138 and TU167. SCCHN cells transduced with either p53, E2F-1, or both underwent in vitro growth analysis, which revealed that simultaneous p53 and E2F-1 gene transfer did not result in enhanced growth inhibition. To explain our growth assay findings on the basis of potential negative molecular interactions between E2F-1 and p53, Western and Northern blotting analyses were performed to investigate the differential expression of the downstream p53-transactivated genes, p21Waf1 and BAX, under various p53 and E2F-1 gene transfer conditions. Whereas Western immunoblotting demonstrated that E2F-1 antagonized p53 induction of p21Waf1 and BAX, Northern blotting revealed that this interference was pretranslationally regulated and p53 dependent. Coimmunoprecipitation assay confirmed that the wild-type p53 and E2F-1 gene products formed protein-protein complexes in our cell lines. Our in vitro data demonstrated that in SCCHN, E2F-1 interferes with induction of p53-transactivated genes, probably through the formation of protein-protein complexes. Simultaneous p53 and E2F-1 gene transfer is not therapeutically advantageous in this in vitro model of SCCHN.

This article has been cited by other articles:

				J.-K. Hsieh, D. Yap, D. J. O'Connor, V. Fogal, L. Fallis, F. Chan, S. Zhong, and X. Lu Novel Function of the Cyclin A Binding Site of E2F in Regulating p53-Induced Apoptosis in Response to DNA Damage Mol. Cell. Biol., January 1, 2002; 22(1): 78 - 93. [Abstract] [Full Text] [PDF]

				T. Itoshima, T. Fujiwara, T. Waku, J. Shao, M. Kataoka, W. G. Yarbrough, T.-J. Liu, J. A. Roth, N. Tanaka, and M. Kodama Induction of Apoptosis in Human Esophageal Cancer Cells by Sequential Transfer of the Wild-Type p53 and E2F-1 Genes: Involvement of p53 Accumulation via ARF-mediated MDM2 Down-Regulation Clin. Cancer Res., July 1, 2000; 6(7): 2851 - 2859. [Abstract] [Full Text]

				H. L. Yang, Y. B. Dong, M. J. Elliott, T. J. Liu, and K. M. McMasters Caspase Activation and Changes in Bcl-2 Family Member Protein Expression Associated with E2F-1-mediated Apoptosis in Human Esophageal Cancer Cells Clin. Cancer Res., April 1, 2000; 6(4): 1579 - 1589. [Abstract] [Full Text]

				H. L. Yang, Y. B. Dong, M. J. Elliott, T. J. Liu, C. Atienza Jr., A. Stilwell, and K. M. McMasters Adenovirus-mediated E2F-1 Gene Transfer Inhibits MDM2 Expression and Efficiently Induces Apoptosis in MDM2-overexpressing Tumor Cells Clin. Cancer Res., August 1, 1999; 5(8): 2242 - 2250. [Abstract] [Full Text] [PDF]

				M. J. Frederick, P. R. Holton, M. Hudson, M. Wang, and G. L. Clayman Expression of Apoptosis-related Genes in Human Head and Neck Squamous Cell Carcinomas Undergoing p53-mediated Programmed Cell Death Clin. Cancer Res., February 1, 1999; 5(2): 361 - 369. [Abstract] [Full Text] [PDF]